|View printer-friendly version|
|Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2007 on February 5, 2007|
BOULDER, Colo.--(BUSINESS WIRE)--Jan. 30, 2007--Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2007 on Monday, February 5, 2007, and will hold a conference call on Tuesday, February 6, 2007, at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
Conference Call Information Date: Tuesday, February 6, 2007 Time: 9:00 a.m. eastern time Toll-Free: 800-500-0177 Toll: 719-457-2679 Pass Code: 4367554 Web Cast: www.arraybiopharma.com
A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free 888-203-1112 or 719-457-0820. The access code is 4367554.
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies access Array's drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc. Tricia Haugeto, 303-386-1193 firstname.lastname@example.org SOURCE: Array BioPharma Inc.